EVELYN V. COONRAD; R. W. RUNDLES, F.A.C.P.
Ovarian carcinoma is the third most common malignancy arising from the female genital tract, and the one least amenable to successful treatment.1, 2 The tumor is notoriously "silent." Its discovery at an early stage is difficult, even in women who have frequent, routine pelvic examinations. Papanicolaou cytologic studies ordinarily give no clue as to its presence, and symptoms are unusual until invasion of the retroperitoneal pelvic tissues, bladder or bowel wall or intraperitoneal spread has occurred. At operation, viable tumor cells have been found in peritoneal washings in the great majority of patients, including many of those without visible metastases.3,
Learn more about subscription options.
Register Now for a free account.
COONRAD EV, RUNDLES RW. MUSTARD CHEMOTHERAPY IN OVARIAN CARCINOMA(MUSTARD CHEMOTHERAPY IN OVARIAN CARCINOMA*†)(MUSTARD CHEMOTHERAPY IN OVARIAN CARCINOMA*†). Ann Intern Med. 1959;50:1449–1461. doi: 10.7326/0003-4819-50-6-1449
Download citation file:
Published: Ann Intern Med. 1959;50(6):1449-1461.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only